Peter Oliver

AI offers unprecedented advantages to the healthcare industry, from reduced administrative burden to improved patient outcomes. However, it also brings new challenges, especially in addressing cybersecurity and data privacy concerns. 78% of respondents in a Deloitte survey indicated that enhancing cybersecurity is a priority in 2025.

The Euthanasia Prevention Coalition, Delta Hospice Society, and The B.C. Catholic are inviting Canadians to share their personal stories about euthanasia/medical assistance in dying (MAiD). These first-hand accounts are being published in one place to give voice to those directly affected by the expansion of Canada’s assisted suicide laws. Sharing these stories highlights the human cost of MAiD and supports efforts to protect the vulnerable. To contribute, email with the subject line MAiD Stories.

Nucleic Acid Insights 2024; 1(3), 127–138 DOI: 10.18609/nai.2024.018 A major challenge associated with oligonucleotide nucleic acid therapeutics is the difficulty of these relatively large and often highly charged molecules to cross cellular membranes and reach their sites of action in the cytosol or nucleus. Consequently, unfavorable pharmacokinetic or pharmacodynamic properties and inefficient cellular uptake currently limit their full translational potential.